Synapse - Karthik Nath

Results (35)

Predictors and implications of renal injury after CD19 chimeric antigen receptor T-cell therapy

Journal Article

Boardman, A. P.; Gutgarts, V.; Flynn, J. R.; Devlin, S. M.; Goldman, A.; Tomas, A. A.; Fein, J. A.; Slingerland, J. B.; Parascondola, A.; Lin, R. J.; more...
Haematologica (2025)

Fulltext@MSK | Save

Infectious complications during treatment with commercial CAR T-cell therapy and bispecific antibodies for relapsed/refractory multiple myeloma

Meeting Abstract

Jurgens, E. M.; Shekarkhand, T.; Farzana, T.; Rueda, C.; Nemirovsky, D.; Derkach, A.; Firestone, R. S.; Nishimura, N.; Miller, K.; Costa, B. A.; more...
Blood (2024)

Fulltext@MSK | Save

Young matched unrelated donors should be prioritized over older-aged matched sibling donors and young haploidentical donors in allogeneic transplantation with post-transplant cyclophosphamide in recipients ≥ 50-years

Meeting Abstract

Nath, K.; Zhang, M. J.; Bye, M.; Lee, S.; Bolon, Y. T.; Benjamin, C.; Betts, B.; Gadalla, S.; Marsh, S. G. E.; Mehta, P.; more...
Bone Marrow Transplantation (2024)

Fulltext@MSK | Save

Superior disease control with younger matched unrelated donor vs older-aged matched sibling donor in recipients ≥ 50-years with ALL, AML, or MDS using CNI-based GVHD prophylaxis

Meeting Abstract

Nath, K.; Zhang, M. J.; Bye, M.; Lee, S.; Bolon, Y. T.; Benjamin, C.; Betts, B.; Gadalla, S.; Marsh, S. G. E.; Mehta, P.; more...
Bone Marrow Transplantation (2024)

Fulltext@MSK | Save

Adjuvant rituximab and elevated intratumoural CD8 expression are associated with sustained disease control after radiotherapy in a randomised trial of systemic therapy in early-stage follicular lymphoma

Journal Article

MacManus, M. P.; Seymour, J. F.; Tsang, H.; Fisher, R.; Keane, C.; Sabdia, M. B.; Law, S. C.; Gunawardana, J.; Nath, K.; Kazakoff, S. H.; more...
EBioMedicine (2024)

Fulltext@MSK | Save

Incidence and clinical impact of acute kidney injury: A comparison of CAR T-cell and bispecific antibody therapies

Meeting Abstract

Nishimura, N.; Mailankody, S.; Nemirovsky, D.; Derkach, A.; Costa, B.; Farzana, T.; Jurgens, E.; Firestone, R.; Nath, K.; Chung, D.; more...
Clinical Lymphoma, Myeloma and Leukemia (2024)

Fulltext@MSK | Save

Intra-tumoral and peripheral blood TIGIT and PD-1 as immune biomarkers in nodular lymphocyte predominant Hodgkin lymphoma

Journal Article

Gunawardana, J.; Law, S. C.; Sabdia, M. B.; Fennell, É; Hennessy, A.; Leahy, C. I.; Murray, P. G.; Bednarska, K.; Brosda, S.; Trotman, J.; more...
American Journal of Hematology (2024)

Fulltext@MSK | Save

Comparison of infectious complications with BCMA-directed therapies in multiple myeloma

Journal Article

Nath, K.; Shekarkhand, T.; Nemirovsky, D.; Derkach, A.; Costa, B. A.; Nishimura, N.; Farzana, T.; Rueda, C.; Chung, D. J.; Landau, H. J.; more...
Blood Cancer Journal (2024)

Fulltext@MSK | Save

Prognostic impact of corticosteroid and tocilizumab use following chimeric antigen receptor T-cell therapy for multiple myeloma

Journal Article

Costa, B. A.; Flynn, J.; Nishimura, N.; Devlin, S. M.; Farzana, T.; Rajeeve, S.; Chung, D. J.; Landau, H. J.; Lahoud, O. B.; Scordo, M.; more...
Blood Cancer Journal (2024)

Fulltext@MSK | Save

Reduced-intensity compared to nonmyeloablative conditioning in patients with non-Hodgkin lymphoma undergoing allogeneic hematopoietic stem cell transplantation

Journal Article

Nath, K.; Peterson, K.; Brown, S.; Devlin, S.; Rodriguez, N.; Barker, J.; Giralt, S.; Gyurkocza, B.; Jakubowski, A.; Papadopoulos, E.; more...
Transplantation and Cellular Therapy (2024)

Fulltext@MSK | Save